Nimotuzumab (Nimotuzumab) is the first humanized monoclonal antibody targeting epidermal growth factor receptor (EGFR). Nimotuzumab has cytolytic effects on target tumors through its ability to induce antibody-dependent cell-mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC). Nimotuzumab failed to recognize mouse EGFR.
Molecular Weight:
147656.97
Purity:
>98%
CAS Number:
[828933-51-3]
Formula:
C6566H10082N1746O2056S40
Target:
EGFR/HER2
* VAT and and shipping costs not included. Errors and price changes excepted